KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Shares Outstanding (2016 - 2025)

Elevance Health (ELV) has disclosed Shares Outstanding for 17 consecutive years, with $222.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding fell 4.27% to $222.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $222.0 million, a 4.27% decrease, with the full-year FY2024 number at $227.5 million, down 2.4% from a year prior.
  • Shares Outstanding was $222.0 million for Q3 2025 at Elevance Health, down from $224.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $244.9 million in Q1 2021 to a low of $222.0 million in Q3 2025.
  • A 5-year average of $235.2 million and a median of $235.9 million in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: fell 1.28% in 2024, then decreased 4.27% in 2025.
  • Elevance Health's Shares Outstanding stood at $241.8 million in 2021, then fell by 1.57% to $238.0 million in 2022, then fell by 2.06% to $233.1 million in 2023, then dropped by 2.4% to $227.5 million in 2024, then fell by 2.42% to $222.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Shares Outstanding are $222.0 million (Q3 2025), $224.8 million (Q2 2025), and $225.7 million (Q1 2025).